99-21639. Ethics Subcommittee of the Advisory Committee to the Director, Centers for Disease Control and Prevention: Meeting

[Federal Register Volume 64, Number 161 (Friday, August 20, 1999)]
[Notices]
[Page 45552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-21639]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Ethics Subcommittee of the Advisory Committee to the Director, 
Centers for Disease Control and Prevention: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following subcommittee meeting.

    Name: Ethics Subcommittee of the Advisory Committee to the 
Director, CDC.
    Time and Date: 8:30 a.m.-5:00 p.m., September 23, 1999.
    Place: Centers for Disease Control and Prevention, 1600 Clifton 
Road, NE, Building 16, Room 5126, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 25 people.
    Purpose: This subcommittee will anticipate, identify, and 
propose solutions to strategic and broad ethical issues facing CDC.
    Matters to be Discussed: Agenda items will include updates from 
the Associate Director for Science, Dixie E. Snider, M.D., M.P.H.; a 
discussion on recommendations for preventing transmission of 
Hepatitis B virus, Hepatitis C virus, and Human Immunodeficiency 
Virus to patients in healthcare settings; and anticipating issues 
involved in future decisions regarding the rotavirus vaccine.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Kathy Cahill, Executive 
Secretary, Advisory Committee to the Director, CDC, 1600 Clifton 
Road, NE, M/S D-24, Atlanta, Georgia 30333. Telephone [phone].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: August 12, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 99-21639 Filed 8-19-99; 8:45 am]
BILLING CODE 4163-18-P